Sanofi (SNY) Non-cash Items (2009 - 2025)

Sanofi (SNY) has 17 years of Non-cash Items data on file, last reported at $4.5 billion in Q2 2025.

• Quarterly Non-cash Items rose 15.95% year-over-year to $4.5 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $4.5 billion (up 15.95% YoY) and the FY2023 annual result came in at $10.3 billion, down 13.25% from the prior year.
• Non-cash Items climbed to $4.5 billion in Q2 2025 per SNY's latest filing, from $3.9 billion in the prior quarter.
• The five-year high for Non-cash Items was $11.5 billion in Q4 2022, with the low at $3.9 billion in Q2 2024.
• Average Non-cash Items over 5 years is $6.9 billion, with a median of $5.1 billion recorded in 2021.
• Year-over-year, Non-cash Items surged 18949.42% in 2021 and declined 18.57% in 2024.
• Sanofi's Non-cash Items stood at $10.4 billion in 2021, then advanced by 9.93% to $11.5 billion in 2022, then fell by 10.87% to $10.2 billion in 2023, then sank by 61.96% to $3.9 billion in 2024, then grew by 15.95% to $4.5 billion in 2025.
• Business Quant data shows SNY's Non-cash Items at $4.5 billion in Q2 2025, $3.9 billion in Q2 2024, and $10.2 billion in Q4 2023.